ArticleJournal for immunotherapy of cancer2025

Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer.

Richard McKinnon Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.